Sign In
25 Jun 2019 07:00
Ergomed Plc
("Ergomed" or the "Company")
Β
PDMR Dealing
Β
Ergomed, a company focused on providing specialised services to the pharmaceutical industry, announces that on 24 June 2019, Dr Miroslav Reljanovic, Executive Chairman of the Company, purchased 200,000 ordinary shares of 1 pence each in the Company ("Share(s)") at a price of 303 pence per Share (the "Purchase").
Β
Following the Purchase, Dr Reljanovic's holding in the Company is [11,155,767] Shares (representing [23.97] per cent. of the Company's issued share capital).
Β
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Β
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Β
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Miroslav Reljanovic | |
2 | Reason for the notification | ||
a) | Position/status | Executive Chairman | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Ergomed Plc | |
b) | Legal Entity Identifier | 213800BVS8I9VMC1AP84 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Β Identification code | Ordinary shares of 1 pence each Β Β Β GB00BN7ZCY67 | |
b) | Nature of the transaction | Purchase of Shares | |
c) | Currency | GBP | |
d) | Price(s) and volume(s) | Price(s) | Volume(s) |
303 pence | 200,000 | ||
e) | Aggregated information - Aggregated volume - Price - Aggregated total | Volume: 200,000 ordinary shares of 1 pence each, purchase price of 303 pence per share Aggregated: Β£606,000.00 Β | |
f) | Date of the transaction | 24 June 2019 | |
g) | Place of the transaction | London Stock Exchange, AIM | |
Β
Β
Enquiries:
Β
Ergomed plc | Tel: +44 (0) 1483 402 975 |
Miroslav ReljanoviΔ (Executive Chairman) | |
Richard Barfield (Chief Financial Officer) | |
Numis Securities Limited | Tel: +44 (0) 20 7260 1000 |
Freddie Barnfield (Nominated Adviser) | |
James Black (Broker) | |
Β
Β
Β
Follow the stocks
